{ "Kyztrex for Menopausal Women with Low Testosterone and HSDD", "This study is testing Kyztrex (oral testosterone undecanoate), a daily pill, in menopausal women who have low testosterone and Hypoactive Sexual Desire Disorder (HSDD), which is a reduced interest in sex. Researchers want to see how safe Kyztrex is and how the body processes it. They will also look at whether it helps with HSDD. You might be able to join if you are a woman aged 30 or older, are menopausal, and have low testosterone (below 25 ng/mL). The study plans to enroll 30 participants, but its current recruitment status is unclear.", "design": "This is an open-label study, meaning everyone knows they are receiving Kyztrex. All 30 participants will receive the same daily dose of Kyztrex.", "commitments": "You would take Kyztrex daily for 3 months. You will have blood samples taken at the start, and on days 7, 28, and 56, along with other routine checks like vital signs and questionnaires.", "compensation": "Not stated in the trial record.", "follow_up": "You will have serial blood samples collected for up to 14 days after your last dose of the study drug.", }

Study design

Not specified.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.